New NYU Langone–led study shows these interventions could serve as a care model for the United States.

The National Cancer Act expanded NCI clinical trials networks, which include Perlmutter Cancer Center.

Dr. Catherine S. Diefenbach discusses clinical trials supported by the ECOG-ACRIN cooperative group.

New center looks to advance the study and use of hallucinogenics to treat mental health disorders.

Dr. Vamsidhar Velcheti discusses a promising targeted therapy based on the results of a clinical trial.

Dr. Joshua K. Sabari discusses a new drug for people with a rare form of non-small cell lung cancer.

The studies’ span speaks to NYU Langone’s strong ability to lead multicenter trials in rheumatology.

Faced with countless unknowns, researchers hunt for therapeutics and vaccines to foil COVID-19.

Researchers investigate clues to help diagnose and treat Parkinson’s disease before symptom onset.

Experts use clinical expertise and basic science research to diagnose a rare autoimmune disorder.